Evidence map›Paper›PMID 42651802›Full record

ArticleCurrent issues in molecular biology2026

The Characterization of a New AG-II-like Glycoprotein from

Mu Dan, Peng Zhao, Lu Ga, Wenming Bai, Pengwei Zhao, Han Ge, Ruirui Wang, Surina Bo, Munkhtsetseg Baatar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mu DanDepartment of Chemical and Biological Engineering, School of Engineering and Technology, National University of Mongolia, Ulaanbaatar 14201, Mongolia.
Peng ZhaoCollege of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Lu GaCollege of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Wenming BaiCollege of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.
Pengwei ZhaoCollege of Basic Medicine, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.ORCID 0000-0002-2526-5705
Han GeShanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID 0009-0008-5550-507X
Ruirui WangShanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Surina BoCollege of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, China.ORCID 0000-0003-4828-5327
Munkhtsetseg BaatarDepartment of Chemical and Biological Engineering, School of Engineering and Technology, National University of Mongolia, Ulaanbaatar 14201, Mongolia.ORCID 0000-0002-2003-7156

Funding

National Natural Science Foundation of China 22167019the Natural science fund of Inner Mongolia Medical University YKD2023MS076the Natural science Fund of Inner Mongolia Province 2023LHMS03023
6 · The paper itself

Abstract

The structural and immunomodulatory properties of arabinogalactan proteins (AGPs) from edible medicinal plants remain largely unexplored. Here, A homogenous AG-II-like arabinogalactan protein (CTSP-W2, 9862 Da) was isolated from

Indexed as

Cynanchum thesioides (Freyn) K. Schumglycoproteinimmunostimulatory activitysignaling pathwaysstructural characterization

Identifiers

PMID42651802
PMCPMC13510445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.